Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-050874

President and CEO acquired 1,662 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2023-06-30 Grant or award +1,662 $10.68 $17,750 1,662 D
Loading xslF345X05/doc4.xml…